Benzinga | Dec 2, 2021 08:03AM EST

DarioHealth Announces 2 New Contracts Within Employer, Provider Market; Terms Not Disclosed

DarioHealth Corp. (NASDAQ:DRIO), a leader in the global digital therapeutics (DTx) market, announced new contracts today to provide its highly personalized digital therapeutics beginning in the first quarter of 2022. The new clients include a regional employer contract for behavioral health, and a strategic partnership in the provider market that will allow Dario solutions to be sold through a network of practices across the United States. The two new contracts mark a key milestone for Dario, bringing its total signed clients to date to more than 50.

Dario's digital therapeutic platform provides proven support for people living with diabetes, pre-diabetes, hypertension, weight management, musculoskeletal and behavioral health needs by addressing the underlying health behaviors with a combination of innovative technologies, digital tools and expert human support. Each solution is fully integrated into a single AI-driven behavior change engine informed by billions of data points collected over ten years of consumer engagement to create a holistic, seamless member experience proven to deliver sustainable engagement and results.

"Achieving more than 50 signed contracts is something to celebrate after a year of positioning for success in the Business-to-Business (B2B) market. We are also thrilled to be heading into the new year with a robust footprint in the employer market alongside another strategic relationship to help accelerate expansion in the provider market," said Rick Anderson, President and General Manager North America.